These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


131 related items for PubMed ID: 31837989

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Analysis of Spatial Dose-Volume Relationships and Decline in Sexual Function Following Permanent Brachytherapy for Prostate Cancer.
    Peng LC, Mian OY, Lakshminarayanan P, Huang P, Bae HJ, Robertson S, Habtu T, Narang A, Agarwal S, Greco S, Tran P, McNutt T, DeWeese TL, Song DY.
    Urology; 2020 Jan; 135():111-116. PubMed ID: 31454660
    [Abstract] [Full Text] [Related]

  • 23. Analysis of the impact of androgen deprivation therapy on sildenafil citrate response following radiation therapy for prostate cancer.
    Teloken PE, Ohebshalom M, Mohideen N, Mulhall JP.
    J Urol; 2007 Dec; 178(6):2521-5. PubMed ID: 17937948
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Potency preservation after three-dimensional conformal radiotherapy for prostate cancer: preliminary results.
    Wilder RB, Chou RH, Ryu JK, Stern RL, Wong MS, Ji M, Roach M, White RD.
    Am J Clin Oncol; 2000 Aug; 23(4):330-3. PubMed ID: 10955856
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Defining sexual outcomes after treatment for localized prostate carcinoma.
    Schover LR, Fouladi RT, Warneke CL, Neese L, Klein EA, Zippe C, Kupelian PA.
    Cancer; 2002 Oct 15; 95(8):1773-85. PubMed ID: 12365027
    [Abstract] [Full Text] [Related]

  • 30. [Erectile dysfunction evaluation after brachytherapy for low risk prostate adenocarcinoma: prospective study of patients with a baseline IIEF5>16].
    Delage F, Perrouin-Verbe MA, Le Fur E, Papin G, Thoulouzan M, Malhaire JP, Pradier O, Fournier G, Valéri A.
    Prog Urol; 2015 Feb 15; 25(2):68-74. PubMed ID: 25497176
    [Abstract] [Full Text] [Related]

  • 31. There is no correlation between erectile dysfunction and dose to penile bulb and neurovascular bundles following real-time low-dose-rate prostate brachytherapy.
    Solan AN, Cesaretti JA, Stone NN, Stock RG.
    Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1468-74. PubMed ID: 18922652
    [Abstract] [Full Text] [Related]

  • 32. Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation.
    Lehrer S, Cesaretti J, Stone NN, Stock RG.
    BJU Int; 2006 Nov 01; 98(5):979-81. PubMed ID: 17034599
    [Abstract] [Full Text] [Related]

  • 33. Predictive factors for erectile dysfunction in men with prostate cancer after brachytherapy: is dose to the penile bulb important?
    Macdonald AG, Keyes M, Kruk A, Duncan G, Moravan V, Morris WJ.
    Int J Radiat Oncol Biol Phys; 2005 Sep 01; 63(1):155-63. PubMed ID: 16111584
    [Abstract] [Full Text] [Related]

  • 34. Erectile function after stereotactic body radiotherapy for localized prostate cancer.
    Dess RT, Hartman HE, Aghdam N, Jackson WC, Soni PD, Abugharib AE, Suy S, Desai NB, Zumsteg ZS, Mehra R, Morgan TM, Feng FY, Hamstra DA, Schipper MJ, Collins SP, Spratt DE.
    BJU Int; 2018 Jan 01; 121(1):61-68. PubMed ID: 28710895
    [Abstract] [Full Text] [Related]

  • 35. Biochemical failure-rate and preservation of erectile function after prostate seed brachytherapy in early-onset prostate cancer.
    Charrois-Durand C, Taussky D, Delouya G, Liberman D.
    Can J Urol; 2022 Feb 01; 29(1):10986-10991. PubMed ID: 35150220
    [Abstract] [Full Text] [Related]

  • 36. Prediction of erectile function following treatment for prostate cancer.
    Alemozaffar M, Regan MM, Cooperberg MR, Wei JT, Michalski JM, Sandler HM, Hembroff L, Sadetsky N, Saigal CS, Litwin MS, Klein E, Kibel AS, Hamstra DA, Pisters LL, Kuban DA, Kaplan ID, Wood DP, Ciezki J, Dunn RL, Carroll PR, Sanda MG.
    JAMA; 2011 Sep 21; 306(11):1205-14. PubMed ID: 21934053
    [Abstract] [Full Text] [Related]

  • 37. Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05.
    Feigenberg SJ, Lee WR, Desilvio ML, Winter K, Pisansky TM, Bruner DW, Lawton C, Morton G, Baikadi M, Sandler H.
    Int J Radiat Oncol Biol Phys; 2005 Jul 15; 62(4):956-64. PubMed ID: 15989995
    [Abstract] [Full Text] [Related]

  • 38. Nursing considerations in brachytherapy-related erectile dysfunction.
    Stipetich R, Abel LJ, Anderson RL, Butler WM, Wallner KE, Merrick GS.
    Urol Nurs; 2005 Aug 15; 25(4):249-54; quiz 259. PubMed ID: 16225341
    [Abstract] [Full Text] [Related]

  • 39. Erectile dysfunction and sexual quality of life in patients who underwent low-dose-rate brachytherapy alone for prostate cancer.
    Nakai Y, Tanaka N, Asakawa I, Miyake M, Anai S, Yamaki K, Hasegawa M, Fujimoto K.
    Andrologia; 2022 Feb 15; 54(1):e14288. PubMed ID: 34693547
    [Abstract] [Full Text] [Related]

  • 40. A comparison of radiation dose to the bulb of the penis in men with and without prostate brachytherapy-induced erectile dysfunction.
    Merrick GS, Wallner K, Butler WM, Galbreath RW, Lief JH, Benson ML.
    Int J Radiat Oncol Biol Phys; 2001 Jul 01; 50(3):597-604. PubMed ID: 11395225
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.